BACKGROUND: Radiofrequency ablation (RFA) is safe and effective for eradicating
neoplasia in Barrett's esophagus. OBJECTIVE: To evaluate RFA for eradicating early …

Radiofrequency ablation (RFA), with or without endoscopic mucosal resection (EMR), is a
safe, effective, and durable treatment option for Barrett esophagus (BE)–associated …

Background and Aims Previous estimates of incidence of intestinal metaplasia (IM)
recurrence after achieving complete remission of IM (CRIM) through endoscopic therapy of …

Background & Aims Complete eradication of Barrett's esophagus (BE) often requires
multiple sessions of radiofrequency ablation (RFA). Little is known about the effects of case …

Introduction Current guidelines recommend endoscopic eradication therapy (EET) for
Barrett's esophagus (BE) with dysplasia and intramucosal adenocarcinoma using either …

Methods In our base case analysis, the simulated cohort was composed of men born in
1950 with BE diagnosed at age 60. Patients were tracked for EAC incidence and mortality …

Results: The safety cohort included 429 patients (71% men, median age 59 years, median
Barrett's segment 3.0 cm). There were no serious adverse events (bleeding, perforation …

Results: Complete Barrett's esophagus eradication was achieved in seven patients, and
partial eradication was achieved in three. There were no major complications. One case of …

Background & Aims Radiofrequency ablation (RFA) with or without endoscopic mucosal
resection (EMR) is routinely used for treatment of Barrett's esophagus with dysplasia …

Objective After focal endoscopic resection (ER) of high-grade dysplasia (HGD) or early
cancer (EC) in Barrett's oesophagus (BO), eradication of all remaining BO reduces the …